Trial intelligence / Profile preview

Olanzapine for PONV Prevention in Laparoscopic Surgery

NCT04718727Phase 2Completed

Start
Mar 2021
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of olanzapine in postoperative nausea and vomiting (PONV). Started Mar 2021; status: completed.

02

Drugs

olanzapine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT04718727.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04718727.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call